Technical Analysis for GNBT - Generex Biotechnology Corporatio

Grade Last Price % Change Price Change
grade D 1.97 0.00% 0.0000
GNBT closed unchanged on Friday, October 18, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical GNBT trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -1.50%
Oversold Stochastic Weakness -1.50%

Older signals for GNBT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency, while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.
Medicine Medical Specialties Branches Of Biology Cancer Immune System Immunotherapy Autoimmune Diseases Drug Delivery Platform Technology Drug Delivery Systems Platform Technologies Antigen T Cell
Is GNBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.3
52 Week Low 0.65
Average Volume 96,830
200-Day Moving Average 1.9378
50-Day Moving Average 2.25
20-Day Moving Average 2.1532
10-Day Moving Average 2.0147
Average True Range 0.1475
ADX 15.19
+DI 18.9011
-DI 20.4177
Chandelier Exit (Long, 3 ATRs ) 2.2975
Chandelier Exit (Short, 3 ATRs ) 2.3425
Upper Bollinger Band 2.5661
Lower Bollinger Band 1.7403
Percent B (%b) 0.28
BandWidth 38.35222
MACD Line -0.1119
MACD Signal Line -0.0995
MACD Histogram -0.0124
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.0450
Resistance 3 (R3) 2.0467 2.0233 2.0325
Resistance 2 (R2) 2.0233 2.0042 2.0225 2.0283
Resistance 1 (R1) 1.9967 1.9924 1.9850 1.9950 2.0242
Pivot Point 1.9733 1.9733 1.9675 1.9725 1.9733
Support 1 (S1) 1.9467 1.9542 1.9350 1.9450 1.9158
Support 2 (S2) 1.9233 1.9424 1.9225 1.9117
Support 3 (S3) 1.8967 1.9233 1.9075
Support 4 (S4) 1.8950